| HS Code | 498018 |
| Product Name | Monodispersed Silica Microsphere |
| Material | Silicon dioxide(SiO2),Non-porous |
| Particle Diameter | 0.5-10μm |
| Solid Content | 5%w/v(silicon hydroxyl ),5%w/v(carboxyl/amino/sulfhydryl/ biotin),1%(streptavidin) |
| Density | 2.0 g/cm3 |
| Refractive Index | ~1.43 – 1.46(589 nm) |
| Surface Modified | silicon hydroxyl /carboxyl/amino/sulfhydryl/ biotin/streptavidin |
| Preserving Fluid | Pure water(containing 0.05%w/v Proclin®300) |
As an accredited Monodispersed Silica Microsphere factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packing sizes is 10/25/50ml, with lot number, purity, particle size, and manufacturer details clearly displayed. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL): Monodispersed Silica Microspheres are securely packed in sealed drums, maximizing space efficiency for safe, bulk export. |
| Shipping | Monodispersed Silica Microspheres are securely packaged in sealed, chemical-resistant containers to prevent contamination and moisture exposure. Shipments are handled with care to ensure particle integrity, often using cushioned packing materials. Delivery is expedited and accompanied by safety documentation, adhering to relevant regulations for laboratory chemicals. Temperature stability is maintained during transit. |
| Storage | Store at 2 – 8°C, do not freeze |
| Shelf Life | Monodispersed silica microspheres typically have a shelf life of 12-24 months when stored in a cool, dry, and sealed container. |
Silica microspheres,unmodified,0.10-5μm | ||||||
0.10μm | 0.30μm | 0.50μm | 1.0μm | |||
unmodified | LWsphere®010Si | LWsphere®030Si | LWsphere®050Si | LWsphere®100Si | ||
2.0μm | 3.0μm | 5.0μm | ||||
unmodified | LWsphere®200Si | LWsphere®300Si | LWsphere®500Si | |||
Competitive Monodispersed Silica Microsphere prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on work with silica have taught us that consistency matters. In research labs, manufacturers, and production lines, even minor size variations in silica particles can throw a project off course. We developed monodispersed silica microspheres to solve exactly this problem. Our process eliminates the guesswork common with broad particle size distributions, offering instead a highly controlled product. These precision-engineered spheres bring clarity and simplicity to workflows that rely on stable, repeatable materials.
Our range covers models with particle diameters from 0.5 µm up to 100 µm. Whether the need is for a few microns or something larger, we maintain a reputation for keeping CV (coefficient of variation) below 5%. That’s not just a number—it’s an outcome of calibrated raw materials, strict synthesis conditions, and regular particle analysis. This level of control gives R&D teams confidence with their process parameters. Those working in diagnostics, chromatography, paint, polymer composites, and optical applications have all pointed out how much easier life becomes with particles that really match what’s on the label.
We start from scratch with pure tetraethyl orthosilicate (TEOS) and pharmaceutical-grade reagents. Our reactors run computer-controlled synthesis cycles, and every batch passes through particle sizing, scanning electron microscopy, and purity checks. If agglomeration or size drift appears, we rework or discard it. The finished product leaves our plant in either aqueous or dry-powder form, based on user preference and downstream requirements. Each lot ships with a full analysis traceable to the production run.
Many in the marketplace offer silica spheres, yet not all products behave the same way under real project conditions. Standard silica can show a broad range of particle sizes due to bulk precipitation or insufficient process monitoring. Some producers rely on mechanical milling, leaving debris or generating irregular shapes. Others may cut corners on raw material purity, introducing unwanted ions or organic residues.
In contrast, our monodispersed microspheres grow by carefully controlled hydrolysis and condensation. No mechanical grinding enters the process. This means almost every sphere appears as a perfect, non-porous bead when viewed under a microscope. The difference matters: Analytical devices dependent on precise bead size—such as flow cytometers or HPLC columns—report sharper baselines and improved calibration outcomes. Paints and coatings spread more evenly, optical measurements become reliable, and composite mechanical strength hits targets with fewer iterations. Feedback from customers shows that predictable supply of the same product over time reduces process failures and streamlines QC protocols.
Factories and laboratories working with batch-to-batch or lot-to-lot variation carry higher operational risk. Production downtime, paired with increased statistical process control, drains resources quickly. With monodispersed silica microspheres, quality engineers can set tighter control limits, freeing up capacity for innovation rather than troubleshooting.
Take a common example from diagnostics: Latex agglutination and flow cytometry count on predictable particle size and surface chemistry. Too much variation, or contamination by other ions, skews measurement accuracy. By sticking to strict production criteria and rejecting out-of-spec material, we help customers reduce their false positives and negatives.
Customers running chromatography columns can also find themselves in trouble with irregular silica. Channeling, backpressure spikes, or unexplained baseline drift often point to resin beads that deviate from their supposed size range. With each production run, we maintain particle sizing logs and comparison charts to ensure downstream system performance remains stable. These details allow users to swap batches with confidence.
Quality isn’t a slogan for us—it sits at the center of every decision we make. We track all process variables, from reagent delivery to temperature ramps, as part of our continuous improvement program. Each production run comes under scrutiny, supported by statistical sampling and off-line analysis: laser diffraction, SEM, zeta potential, and residual solvent checks.
Long-term storage stability tests for our silica microspheres run for years here before we ever release a batch to the market. Caked powder, instability in suspension, or the presence of microbubbles lead to rejection. High-purity protocols keep metal, chloride, and ammonium content to levels suitable for critical applications—often chromatographic media for pharmaceutical and food chains.
We have seen applications fail with low-grade “silica beads” in flow cytometry. A project once collapsed when a customer’s commercial microscope started producing unreliable cell counts. After checking their entire workflow, we analyzed their bead batch and found wide deviations from the stated CV, along with visible surface pits. We swapped them to our monodispersed line, and they regained count consistency, shaving measurable time off their entire sample workflow. We see similar stories nearly every month, highlighting the value of supplying what’s actually promised.
Since pure silica alone does not always fit every user’s application, we expanded into custom surface modification. By grafting carboxyl, amine, or aldehyde groups, our microspheres become compatible with covalent attachment protocols for bioassays, immunoassays, or specific binding studies. Chemists and biologists often prefer these options, since a controlled density and uniform distribution of surface groups minimize non-specific binding and step-to-step loss.
We avoid the addition of surfactants or questionable stabilizers, since these can leach and act as process contaminants later. Surface functionalization steps are verified through titration, colorimetry, and fluorescence studies, not just IR or simple spot tests. That way, users receive particles ready to work straight from the jar, without pre-washing or elaborate conditioning.
Our monodispersed silica products now underpin projects in drug delivery, microfluidics, and emerging photonic devices. Medical device startups, academic groups, and advanced materials manufacturers approach us with development projects that demand not only size control, but complete transparency. We work closely with in-process auditors and regulatory staff to share every step of the production and quality assurance workflow. Customers needing particles with partial porosity or alternate surface modification get bespoke manufacturing backed by systematic batch retention and reference archiving.
In additive manufacturing and 3D printing for electronics, smooth, spherical filler material at tightly held diameters determines whether a run succeeds or ends up in scrap. Our silica microspheres allow for predictable sintering and consistent layer stacking, both of which have mattered for repeated successful builds.
Manufacturing fine chemicals such as silica particles produces waste that can stress both local resources and regulatory limits. We invested early in closed-cycle solvent recovery and water purification. Each ton of product leaves our plant with a minimized waste footprint—much less than conventional bulk silica or commodity-grade material producers. By avoiding certain toxic solvents, we keep our operation suitable for adjacent neighborhoods and meet stringent safety requirements. This approach isn’t just about compliance; it’s reinforced by feedback from sustainability-minded clients who audit our process for their own supply chain certifications.
Our team responds quickly to changing regulations or third-party scrutiny. Over the past decade, standards shifted and new requirements for nanomaterial tracking emerged. Internally, every process gets regularly reviewed for hazardous material reduction, cleanroom operation efficiency, and recyclability of packaging.
Working at the source lets us move quickly when specifications change on short notice. Research customers rely on highly specialized requirements—if a protein labeling assay begins to fail, or a new analytical method comes in, we stand ready to test material modifications in real-time with our own engineers. Adjusting particle diameter, surface chemistry, or suspension medium doesn’t take weeks of procurement and coordination. Instead, we support beta projects and process changes with the same equipment used for standard production.
During early pandemic supply crunches, several labs experienced delays or missed shipments from international traders unable to access manufacturers directly. Customers who had previously worked with brokers or packaged goods found themselves waiting for explanations and failing to resolve sudden shipping or customs issues. In contrast, as direct manufacturers, we kept feeding our local and global clients without production interruptions. Close relationships with transport partners, clarity with documentation, and the ability to react to feedback gave our users a degree of reliability missing from indirect supply chains.
Over the past decade, global laboratories, electronics manufacturers, and pharmaceutical companies have given us direct feedback on product batches, test results, and QC failures from other suppliers. We use these details to revise both quality assurance and customer support systems. Each complaint or suggestion triggers an internal review of operating procedures and batch data, with successful changes incorporated into our next production runs.
Independent labs have compared our monodispersed silica against standard precipitation or milled silica in performance tests for scattering, light transmittance, and chemical reactivity. In almost every head-to-head, our products show lower baseline drift in analytical methods and improved reproducibility. Our analytical team documents these studies—some published by partners in open-access journals—and archives them to help new clients understand what to expect. Potential buyers often request this evidence before committing, and we share full datasets under standard NDAs.
Many applications require verifiable compliance with ISO, FDA, and local regulatory directives. We maintain active certification and audit processes for both standard silica and surface-modified lines. Materials traveling into sensitive applications, especially in pharmaceuticals or diagnostics, ship with full documentation, including lot traceability, composition breakdown, and contaminant registers. For internationally regulated projects, we keep batch samples in climate-controlled archives for follow-up or third-party review, responding to queries within standard working days.
Unlike some suppliers who hand off regulatory responsibility to resellers or end-users, our staff guide customers through the paperwork. Document preparation, consultation with auditors, and support for data gathering don’t get outsourced. In partnership with QA staff from our clients’ teams, we identify any documentation gaps and fill them, often expediting approvals and market entry.
Our relationship with research users often goes far beyond simple supply. Years ago, a nanoelectronics company approached us after several production runs failed due to inconsistent particle electrical properties. Working with their engineering and analytical team, we produced a specialized run of low-sodium, monosized silica, which significantly improved the yield and device performance. They moved from pilot to full production without the scaling headaches that plagued earlier attempts.
Another client from the polymer coatings space saw support during a line expansion. Paints prepared with broad-range silica left a streaky appearance under certain conditions. After switching to our standardized microspheres, their process changes included tweaks to batching but no major production equipment overhaul. The outcome saved tens of thousands in downtime and reduced field complaints markedly.
Silica spheres may seem simple, but years of batch records and tens of thousands of user hours speak to the complexity involved. Particle size, shape, purity, and surface chemistry interact in ways that, if left uncontrolled, can derail even robust processes. Producing monodispersed spheres is less about commodity scale and more about process mastery; we have turned our focus through regular investment in analytics, careful staff training, and a willingness to reconsider each small change that could lead to improvement.
Our staff maintain open communication with users not just as sales, but as partners in experimentation. We routinely send test lots, incorporate feedback in next-generation models, and share results that have nothing to do with direct sales. Once, a biomedical startup asked for a unique batch coated with a rare ligand. The first run fell short of required binding efficiency, but closely documented modifications let us iterate rapidly, arriving at a final protocol that shaved weeks off the expected timeline.
We recognize that new applications keep arriving, many with needs that challenge or exceed those that came before. Our response remains grounded in listening—both to the market and to scientific advances that push older manufacturing paradigms. Whether it’s dropping the particle CV a fraction of a percent, advancing greener chemistry, or expanding documentation, we view each step as a means to enable our clients. The result: a reliable silica microsphere that delivers not just by specification, but in performance and support through its entire lifecycle.